The impact of pharmacogenetics for migraine
- 9 February 2001
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 413 (1) , 1-10
- https://doi.org/10.1016/s0014-2999(00)00949-3
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Genetic heterogeneity in Italian families with familial hemiplegic migraineNeurology, 1999
- A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxiaNeurology, 1999
- Recurrence of the T666M Calcium Channel CACNA1A Gene Mutation in Familial Hemiplegic Migraine with Progressive Cerebellar AtaxiaAmerican Journal of Human Genetics, 1999
- Association between dopamine receptor genes and migraine without aura in a Sardinian sampleNeurology, 1998
- The D2 receptor Nco I allele: Absence of allelic association with migraine with auraNeurology, 1998
- A practical guide to the management and prevention of migraine.Drugs, 1998
- Mapping of a second locus for familial hemiplegic migraine to 1q21–q23 and evidence of further heterogeneityAnnals of Neurology, 1997
- Sodium Channel Defects in Myotonia and Periodic ParalysisAnnual Review of Neuroscience, 1996
- Neuroexcitatory plasma amino acids are elevated in migraineNeurology, 1990
- Serotonin metabolism in migraineNeurology, 1989